DFTX: Leerink Raises Target
Leerink Partners maintains Outperform on Definium Therapeutics and raises price target to $52
Leerink Partners Maintains Outperform on Definium Therapeutics, Raises Price Target to $52
Leerink Partners maintains Outperform on Definium Therapeutics and raises price target to $52
Leerink Partners Maintains Outperform on Definium Therapeutics, Raises Price Target to $52